CELTAXSYS
Celtaxsys, is a biopharmaceutical company, engages in developing and testing drug compounds for treating cancer, and inflammatory and autoimmune diseases. Its technology manipulates immune cell migration as a treatment for cancer, inflammation, and organ/tissue rejection. The company's drug compounds are designed to block the protective mechanisms created by certain tumors to prevent attack by immune system cells.
CELTAXSYS
Social Links:
Industry:
Biopharma Biotechnology Health Care
Founded:
2004-01-01
Address:
Atlanta, Georgia, United States
Country:
United States
Website Url:
http://www.celtaxsys.com
Total Employee:
11+
Status:
Closed
Contact:
(404) 920-0702
Email Addresses:
[email protected]
Total Funding:
65.16 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible GoDaddy DNS Google Google Cloud Pound Sterling OpenResty Japanese Yen Google Adsense Google Cloud Global Multi-Region
Similar Organizations
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Kamada
Kamada is a biopharmaceutical company engaged in developing, producing and marketing of specialty life-saving therapeutics, using a unique
Mast Therapeutics
Mast Therapeutics is a biopharmaceutical company developing novel, clinical-stage therapies for serious or life-threatening diseases.
Otonomy
Otonomy is a biopharmaceutical company developing and commercializing treatments for diseases of the inner and middle ear.
Palisade Bio
Palisade Bio is a clinical-stage biopharmaceutical company developing novel therapies for acute and chronic gastrointestinal complications.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Founder
Investors List
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Grant - Celtaxsys
Lumira Ventures
Lumira Ventures investment in Series E - Celtaxsys
RMI Partners
RMI Partners investment in Series E - Celtaxsys
Georgia Research Alliance
Georgia Research Alliance investment in Series E - Celtaxsys
Masters Capital Management
Masters Capital Management investment in Series E - Celtaxsys
Invus
Invus investment in Series E - Celtaxsys
Domain Associates
Domain Associates investment in Series E - Celtaxsys
GRA Venture Fund, LLC
GRA Venture Fund, LLC investment in Series D - Celtaxsys
Domain Associates
Domain Associates investment in Series D - Celtaxsys
Lumira Ventures
Lumira Ventures investment in Series D - Celtaxsys
Official Site Inspections
http://www.celtaxsys.com Semrush global rank: 4.37 M Semrush visits lastest month: 2.58 K
- Host name: ec2-54-243-117-197.compute-1.amazonaws.com
- IP address: 54.243.117.197
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Celtaxsys"
Celtaxsys - Crunchbase Company Profile & Funding
Celtaxsys, is a biopharmaceutical company, engages in developing and testing drug compounds for treating cancer, and inflammatory and autoimmune diseases. Its technology manipulates …See details»
Celtaxsys Company Profile 2024: Valuation, Funding & Investors
Who are Celtaxsys’s competitors? Codiak BioSciences, Emerald Health Pharmaceuticals, Synlogic, XBiotech, and Jnana Therapeutics are some of the 24 competitors of Celtaxsys. …See details»
Celtaxsys Company Profile - Office Locations, Competitors ... - Craft
Celtaxsys is a pharmaceutical company developing treatments for patients with rare inflammatory diseases including cystic fibrosis. It provides an investigational medicine, acebilustat, as a …See details»
Celtaxsys, Inc. Company Profile | Foxboro, MA - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Celtaxsys, Inc. of Foxboro, MA. Get the latest business insights from Dun & Bradstreet.See details»
Celtaxsys Inc - Company Profile and News - Bloomberg Markets
Company profile page for Celtaxsys Inc including stock price, company news, executives, board members, and contact informationSee details»
Celtaxsys - Products, Competitors, Financials, Employees, …
Celtaxsys is a clinical-stage pharmaceutical development company focused on advancing novel foundational therapies to treat inflammation in rare, orphan designated diseases. The …See details»
Celtaxsys - VentureRadar
Celtaxsys is a privately-held drug discovery and development company focused on advancing treatments for serious inflammatory diseases. The company is building a sustainable pipeline …See details»
Celtaxsys - Funding, Financials, Valuation & Investors - Crunchbase
Celtaxsys is funded by 8 investors. Cystic Fibrosis Foundation and Lumira Ventures are the most recent investors. Celtaxsys has a post-money valuation in the range of $100M to $500M as of …See details»
Celtaxsys - Crunchbase
Celtaxsys is a biopharmaceutical company, engages in developing and testing drug compounds for treating cancer.See details»
Celtaxsys Inc. - BioCentury Company Profiles - BCIQ
Celtaxsys Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Working At Celtaxsys: Company Overview and Culture - Zippia
Celtaxsys Rankings. Celtaxsys is ranked #10 on the Best Pharmaceutical Companies to Work For in Georgia list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of …See details»
Celtaxsys Secures $45M in Capital to Fund Novel Anti …
ATLANTA, June 8, 2015 -- Celtaxsys, Inc., a clinical stage drug development company focused on developing novel therapies for inflammatory diseases, today announced the successful …See details»
Celtaxsys, Inc. Restructures Management and Operations; CEO, …
Sep 12, 2013 Celtaxsys Restructures, Enhances Operational Focus ATLANTA, Sept. 9, 2013 /PRNewswire/ -- Celtaxsys, Inc., an Atlanta-based pharmaceutical discovery and development …See details»
Celtaxsys announces the issue of four new patents expanding its ...
Feb 1, 2018 About Celtaxsys: Celtaxsys is a privately-held drug discovery and development company focused on advancing treatments for serious inflammatory diseases. The company is …See details»
Celtaxsys' Lead Pipeline Immuno-Modulator for CF Granted …
Feb 10, 2015 Celtaxsys, Inc., a privately-owned, clinical stage drug discovery and development company focused on addressing serious inflammatory diseases, has just announced the U.S. …See details»
Celtaxsys - Contacts, Employees, Board Members, Advisors & Alumni
Organization. Celtaxsys . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Number of Board Member and Advisor …See details»
Celtaxsys Secures $45M in Capital to Fund Novel Anti …
Jun 8, 2015 The grant will help fund Celtaxsys's Phase 2 trial assessing the safety and efficacy of the company's lead candidate, CTX-4430, a once daily, oral anti-inflammatory medicine, in …See details»
Novel Cystic Fibrosis Treatment Reduces Frequency of …
Aug 20, 2018 Celtaxsys Announces Results of Phase 2 Trial Showing Clinically Meaningful Improvement in Pulmonary Exacerbations in Cystic Fibrosis Patients [news release]. …See details»
Celtaxsys Announces Results Of Phase 2 Trial Showing Clinically ...
Aug 2, 2018 <p>Celtaxsys, Inc., a clinical stage pharmaceutical development company focused on advancing treatments for patients with rare inflammatory diseases, today announced top …See details»
Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of …
Jul 6, 2015 About Celtaxsys: Celtaxsys, Inc. is a privately-held pharmaceutical discovery and development company focused on advancing medicine to treat patients suffering from serious …See details»